These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 39292317)
1. Analysis of the role of CHPF in colorectal cancer tumorigenesis and immunotherapy based on bioinformatics and experiments. Song Q; Wang P; Wu J; Lu M; Xia Q; Shi Y; Wang Z; Ma X; Zhao Q Discov Oncol; 2024 Sep; 15(1):458. PubMed ID: 39292317 [TBL] [Abstract][Full Text] [Related]
2. Bioinformatics and Experimental Analysis of the Prognostic and Predictive Value of the CHPF Gene on Breast Cancer. Li WW; Liu B; Dong SQ; He SQ; Liu YY; Wei SY; Mou JY; Zhang JX; Liu Z Front Oncol; 2022; 12():856712. PubMed ID: 35372047 [TBL] [Abstract][Full Text] [Related]
3. UBR1 is a prognostic biomarker and therapeutic target associated with immune cell infiltration in gastric cancer. Yuan W; Han J; Chen C; Qiu Y; Xu Y; Huang Y; Chen Z; Xu A; Sun M Aging (Albany NY); 2024 Aug; 16(16):12029-12049. PubMed ID: 39181686 [TBL] [Abstract][Full Text] [Related]
4. Tumor microenvironment-related gene selenium-binding protein 1 (SELENBP1) is associated with immunotherapy efficacy and survival in colorectal cancer. Zhu C; Wang S; Du Y; Dai Y; Huai Q; Li X; Du Y; Dai H; Yuan W; Yin S; Wang H BMC Gastroenterol; 2022 Oct; 22(1):437. PubMed ID: 36253721 [TBL] [Abstract][Full Text] [Related]
5. A pan-cancer characterization of immune-related NFIL3 identifies potential predictive biomarker. Fei Q; Zhang X; Wang S; Shu G; Yin G J Cancer; 2024; 15(5):1271-1286. PubMed ID: 38356719 [No Abstract] [Full Text] [Related]
6. Chondroitin polymerizing factor (CHPF) contributes to malignant proliferation and migration of hepatocellular carcinoma cells. Xu Q; Lin W; Tao C; Huang X; Li J Biochem Cell Biol; 2020 Jun; 98(3):362-369. PubMed ID: 32383983 [TBL] [Abstract][Full Text] [Related]
7. Activation of CHPF by transcription factor NFIC promotes NLRP3 activation during the progression of colorectal cancer. Wu J; Wang M; Zhang Y; Liu G; Xing Y Funct Integr Genomics; 2024 Jan; 24(1):20. PubMed ID: 38267731 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinoma. Huang S; Hou Y; Hu M; Hu J; Liu X BMC Cancer; 2022 Sep; 22(1):995. PubMed ID: 36123627 [TBL] [Abstract][Full Text] [Related]
9. The Effects of Differentially-Expressed Homeobox Family Genes on the Prognosis and HOXC6 on Immune Microenvironment Orchestration in Colorectal Cancer. Qi L; Ye C; Zhang D; Bai R; Zheng S; Hu W; Yuan Y Front Immunol; 2021; 12():781221. PubMed ID: 34950145 [TBL] [Abstract][Full Text] [Related]
10. Exploring the correlation of glycolysis-related chondroitin polymerizing factor ( Zhong Q; Jiang K; Zhang F; Tian Y; Gu J; Li T; Chen X; Yang J; Sun F Am J Cancer Res; 2023; 13(6):2213-2233. PubMed ID: 37424829 [TBL] [Abstract][Full Text] [Related]
11. ADAMTSL2 is a potential prognostic biomarker and immunotherapeutic target for colorectal cancer: Bioinformatic analysis and experimental verification. Huang Z; Hu X; Wei Y; Lai Y; Qi J; Pang J; Huang K; Li H; Cai P PLoS One; 2024; 19(5):e0303909. PubMed ID: 38814950 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2. Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y Front Immunol; 2023; 14():1155182. PubMed ID: 37275857 [TBL] [Abstract][Full Text] [Related]
13. Forkhead Box S1 mediates epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway to regulate colorectal cancer progression. Zhang L; Ren CF; Yang Z; Gong LB; Wang C; Feng M; Guan WX J Transl Med; 2022 Jul; 20(1):327. PubMed ID: 35864528 [TBL] [Abstract][Full Text] [Related]
14. Up-Regulated MISP Is Associated With Poor Prognosis and Immune Infiltration in Pancreatic Ductal Adenocarcinoma. Huang X; Zhao L; Jin Y; Wang Z; Li T; Xu H; Wang Q; Wang L Front Oncol; 2022; 12():827051. PubMed ID: 35433491 [TBL] [Abstract][Full Text] [Related]
15. A CLRN3-Based CD8 Gong Z; Huang X; Cao Q; Wu Y; Zhang Q Biomolecules; 2024 Jul; 14(8):. PubMed ID: 39199281 [TBL] [Abstract][Full Text] [Related]
16. MiR-214-3p overexpression-triggered chondroitin polymerizing factor (CHPF) inhibition modulates the ferroptosis and metabolism in colon cancer. Yun ZY; Wu D; Wang X; Huang P; Li N Kaohsiung J Med Sci; 2024 Mar; 40(3):244-254. PubMed ID: 38190270 [TBL] [Abstract][Full Text] [Related]
17. Chondroitin polymerizing factor promotes breast carcinoma cell proliferation, invasion and migration and affects expression of epithelial-mesenchymal transition-related markers. Li Y; Gong H; Feng L; Mao D; Xiao Y; Wang Y; Huang L FEBS Open Bio; 2021 Feb; 11(2):423-434. PubMed ID: 33301643 [TBL] [Abstract][Full Text] [Related]
18. Identification and validation of immunotherapy for four novel clusters of colorectal cancer based on the tumor microenvironment. Zheng X; Ma Y; Bai Y; Huang T; Lv X; Deng J; Wang Z; Lian W; Tong Y; Zhang X; Yue M; Zhang Y; Li L; Peng M Front Immunol; 2022; 13():984480. PubMed ID: 36389763 [TBL] [Abstract][Full Text] [Related]
19. RNA demethylase ALKBH5 suppresses tumorigenesis via inhibiting proliferation and invasion and promoting CD8 Ge J; Liu SL; Zheng JX; Shi Y; Shao Y; Duan YJ; Huang R; Yang LJ; Yang T Transl Oncol; 2023 Aug; 34():101683. PubMed ID: 37224767 [TBL] [Abstract][Full Text] [Related]
20. Chondroitin polymerizing factor predicts a poor prognosis and promotes breast cancer progression via the upstream TGF-β1/SMAD3 and JNK axis activation. Pan QF; Ouyang WW; Zhang MQ; He S; Yang SY; Zhang J J Cell Commun Signal; 2023 Mar; 17(1):89-102. PubMed ID: 36042157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]